Pfizer to Acquire Anacor Pharmaceuticals for .2 Billion
After terminating deals with AstraZeneca and most recently, Allergan, Pfizer has turned to relatively smaller biotech companies for acquisitions.
Showing posts with label Pharmaceuticals. Show all posts
Showing posts with label Pharmaceuticals. Show all posts
Monday, May 16, 2016
Saturday, December 5, 2015
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
The chief of Turing Pharmaceuticals, who increased a drug’s price to $ 750 from $ 13.50 a pill, has been bashed as the face of corporate greed. But he’s still smiling.
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
The chief of Turing Pharmaceuticals, who increased a drug’s price to $ 750 from $ 13.50 a pill, has been bashed as the face of corporate greed. But he’s still smiling.
Tuesday, October 27, 2015
Is Valeant Pharmaceuticals the Next Enron?
Is Valeant Pharmaceuticals the Next Enron?
Allegations about Valeant’s practices and its own disclosures while under pressure cause one to wonder.
Subscribe to:
Posts (Atom)